Publications by authors named "Jianwrong Wu"

Claim this Profile
I
Initial testing (stage 1) of M6620 (formerly VX-970), a novel ATR inhibitor, alone and combined with cisplatin and melphalan, by the Pediatric Preclinical Testing Program.
Raushan T Kurmasheva, Dias Kurmashev, C Patrick Reynolds, Min Kang, Jianwrong Wu

Pediatr Blood Cancer· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program.
Raushan T Kurmasheva, Melissa Sammons, Edward Favours, Jianwrong Wu, Dias Kurmashev

Pediatr Blood Cancer· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial Testing (Stage 1) of MK-8242-A Novel MDM2 Inhibitor-by the Pediatric Preclinical Testing Program.
Min H Kang, C Patrick Reynolds, E Anders Kolb, Richard Gorlick, Hernan Carol, Jianwrong Wu

Pediatr Blood Cancer· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis